MedTrace Logo

Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice

NCT03793283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-01-18

No results posted yet for this study

Summary

Observational study about effectiveness and safety of continuous subcutaneous insulin infusion compared to multiple dose insulin injections in Type 1 Diabetes Mellitus (T1DM) adult patients in routine clinical practice.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

CSII

Currently receiving CSII therapy during 6 or more months.

DRUG

Multiple dose insulin injections

Currently receiving MDI therapy during 6 or more months.

Sponsors & Collaborators

  • University of Castilla-La Mancha

    collaborator OTHER

  • Universidad de Córdoba

    collaborator OTHER

  • Castilla-La Mancha Health Service

    lead OTHER

Principal Investigators

  • Jesus Moreno-Fernandez, PhD · Castilla-La Mancha Public Health Service.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793283 on ClinicalTrials.gov